Suscribirse

Health care worker perceptions toward computerized clinical decision support tools for Clostridium difficile infection reduction: A qualitative study at 2 hospitals - 27/09/18

Doi : 10.1016/j.ajic.2018.04.204 
Natalia Blanco, PhD, MPH a, * , Lyndsay M. O'Hara, PhD, MPH a, Gwen L. Robinson, MPH a, Jeanine Brown, MSN a, Emily Heil, PharmD a, b, Clayton H. Brown, PhD, MS a, Brian D. Stump, PharmD c, Bryant W. Sigler, MS c, Anusha Belani, MD c, Heidi L. Miller, RN d, Amber N. Chiplinski, PharmD d, Rebecca Perlmutter, MPH e, Lucy Wilson, MD, MS e, Daniel J. Morgan, MD, MS a, f, Surbhi Leekha, MBBS, MPH a
a Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 
b Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD 
c Frederick Memorial Hospital, Frederick, MD 
d Meritus Health, Hagerstown, MD 
e Emerging Infections Program, Maryland Department of Health, Baltimore, MD 
f VA Maryland Healthcare System, Baltimore, MD 

*Address correspondence to Natalia Blanco, PhD, MPH, University of Maryland School of Medicine, 10 S Pine St, Ste 360F, Baltimore, MD 21201. (N. Blanco).University of Maryland School of Medicine10 S Pine St, Ste 360FBaltimoreMD21201

Highlights

•
The impact of an electronic Clostridium difficile infection reduction bundle was assessed.
•
Gaps in knowledge and communication between health care workers were observed.
•
A perceived loss of autonomy and clinical judgment was identified.
•
Standardization and automation were perceived benefits.
•
End users agreed the tools could help them to improve the quality of patient care.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Computerized clinical decision support (CCDS) tools can aid process improvement in infection prevention and antibiotic stewardship, but implementation and health care workers (HCWs) uptake of these tools is often variable. The objective of this study was to describe HCWs' perceptions of barriers and facilitators related to uptake of CCDS tools as part of a CDI reduction bundle.

Methods

We conducted a qualitative study among HCWs at 2 acute care hospitals in Maryland. Semi-structured interviews and structured surveys were completed by HCWs to evaluate their perception to CCDS tools at 2 different stages: predevelopment and preimplementation. Emergent themes and patterns in the data were identified and condensed.

Results

Gaps in CDI-related knowledge and in communication between HCWs were identified throughout the evaluation. HCWs agreed on the potential of the tools to improve CDI diagnosis, prevention, and control. An important barrier for uptake was the perceived loss of autonomy and clinical judgment, whereas standardization and error reduction were perceived advantages.

Conclusions

These observations shaped the development and implementation of the CDI reduction bundle. Qualitative findings can provide valuable contextual information during the development stages of CCDS tools in infection prevention and antibiotic stewardship.

El texto completo de este artículo está disponible en PDF.

Key Words : Clostridium difficile infection, computerized clinical decision support, antibiotics, proton-pump inhibitors


Esquema


 Funding/support: Supported by the Centers for Disease Control and Prevention through a Broad Agency Announcement (contract no. 200-2016-91943).
 Conflicts of interest: N.B. reports grants from Centers for Disease Control and Prevention, during the conduct of the study; S.L. reports grants from Centers for Disease Control and Prevention, during the conduct of the study; D.J.M. reports grants from CDC, NIH, AHRQ, VA HSRD, IDSA, other from ASM, Lown and SHEA for expenses to organize or present at national meetings,other from Springer Inc, outside the submitted work; C.B. reports grants from Centers for Disease Control, during the conduct of the study; G.L.R. reports grants from Centers for Disease Control, during the conduct of the study; J.B. reports grants from Centers for Disease Control, during the conduct of the study; L.M.O reports grants from Centers for Disease Control and Prevention, during the conduct of the study; E.H. reports grants from ALK-ABELLO, outside the submitted work; there are no other conflicts to disclose.


© 2018  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 46 - N° 10

P. 1160-1166 - octobre 2018 Regresar al número
Artículo precedente Artículo precedente
  • A microbiological study to investigate the carriage and transmission-potential of Clostridium difficile spores on single-use and reusable sharps containers
  • Terry Grimmond, Anu Neelakanta, Barbara Miller, Asif Saiyed, Pam Gill, Jennifer Cadnum, Russell Olmsted, Curtis Donskey, Kimberly Pate, Katherine Miller
| Artículo siguiente Artículo siguiente
  • Enacting high reliability principles while caring for people with Ebola Virus Disease
  • Bonnie Mowinski Jennings, Katherine A. Yeager, Nancye R. Feistritzer, Mary M. Gullatte, Kristy K. Martyn

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.